Patricia Letondal-Mercier

Besancon, 25000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Metformin dual-targets metabolism and survival pathways in BPDCN.

Metformin dual-targets metabolism and survival pathways in BPDCN.

Journal: iScience
Published: July 30, 2025

Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.

Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.

Journal: Molecular therapy. Methods & clinical development
Published: February 07, 2025

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

Journal: Cancer immunology, immunotherapy : CII
Published: September 30, 2024

Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy.

Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy.

Journal: Frontiers in immunology
Published: April 07, 2023

Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells.

Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells.

Journal: Cancer gene therapy
Published: May 10, 2021

An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cells.

An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cells.

Journal: Cellular immunology
Published: October 12, 2020

Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1).

Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1).

Journal: Journal of translational medicine
Published: September 11, 2020

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.

Journal: International journal of cancer
Published: February 19, 2019

Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.

Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.

Journal: Human gene therapy
Published: August 24, 2018

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment.

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment.

Journal: Oncotarget
Published: June 23, 2018

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Journal: Oncoimmunology
Published: June 20, 2017

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 20, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026